Galt Pharmaceuticals franchise cost, fees and FDD 2026

A pharmaceutical sales business that promotes products owned or licensed by the franchisor, using the franchisor's proprietary system of policies and procedures. These numbers come from Galt Pharmaceuticals's 2026 Franchise Disclosure Document, filed with the state of Minnesota. Each one links to the page of the FDD it comes from.

Not legal or financial advice. Numbers come from each brand's own Franchise Disclosure Document (FDD) as filed with the state of Minnesota; check the linked page of the FDD before you rely on one.

Key numbers

Total investment to open
$122,350 to $348,700home-based pharmaceutical sales business FDD p. 21 (opens the state's PDF)
Initial franchise fee
$100,000 to $300,000Between $100,000 and $300,000, varying by territory location and pharmaceutical sales activity FDD p. 13 (opens the state's PDF)
Royalty
Not found in the FDD
Brand or advertising fund
$1,000 a monthNo fund currently in place; if implemented, then-current marketing fee capped at $1,000 per month per territory FDD p. 16 (opens the state's PDF)
Franchised outlets at the end of 2025
63none owned by the company FDD p. 51 (opens the state's PDF) FDD p. 48 (opens the state's PDF)
Financial performance (Item 19)
DisclosedSee below FDD p. 46 (opens the state's PDF)

Average sales and other results (Item 19)

Galt Pharmaceuticals makes a financial performance representation in Item 19 of its FDD: 24 franchisees operating 53 territories open and operating the entire 2025 calendar year. The headline figures, as the FDD states them:

Read the full Item 19 starting on page 46 (opens the state's PDF) of the FDD.

Item 19 figures are what existing locations reported, under the conditions the FDD describes. They are not a promise of what a new location will earn. Read the whole Item 19, including its notes, from page 46 (opens the state's PDF).

Openings and closures (Item 20)

Franchised outlets by year, all states, from the FDD's Item 20 tables. Company-owned outlets are not included.

YearOpen at startOpenedTerminatedNot renewedReacquired by franchisorCeased operationsOpen at endTransferred to new ownerSource
20236420000662FDD p. 51 (opens the state's PDF) transfers p. 49 (opens the state's PDF)
20246660003693FDD p. 51 (opens the state's PDF) transfers p. 49 (opens the state's PDF)
2025691400200631FDD p. 51 (opens the state's PDF) transfers p. 49 (opens the state's PDF)

Over 2023 to 2025, 3 franchised outlets were terminated, not renewed or stopped operating, against 22 opened. That is 1.5% of the franchised outlets open at the start of each year (our arithmetic on the FDD's table: terminations + non-renewals + ceased operations, divided by the sum of the start-of-year counts).

The FDD projects 15 new franchised outlets in the next year (FDD p. 52 (opens the state's PDF)).

All outlets at the end of each year

Source document

Questions

How much does it cost to open a Galt Pharmaceuticals franchise?

Galt Pharmaceuticals's 2026 FDD estimates a total initial investment of $122,350 to $348,700 for a home-based pharmaceutical sales business (Item 7, page 21). That includes the initial franchise fee of $100,000 to $300,000.

What is the Galt Pharmaceuticals franchise fee?

Galt Pharmaceuticals's 2026 FDD gives an initial franchise fee of $100,000 to $300,000: Between $100,000 and $300,000, varying by territory location and pharmaceutical sales activity (Item 5, page 13).

Does Galt Pharmaceuticals publish average sales in Item 19?

Yes. The figures cover 24 franchisees operating 53 territories open and operating the entire 2025 calendar year. See Item 19 from page 46.

How many Galt Pharmaceuticals franchises closed?

From 2023 to 2025, 3 franchised outlets were terminated, not renewed or ceased operations, and 22 opened (Item 20).

Other other franchises

All other franchises

Numbers checked against the FDD's text on 2026-11-16. Spotted a wrong number? Tell us.